Biden administration officials have said the U.S. expects J&J to release 3 million to 4 million shots next week, assuming it’s authorized for use. The company is ready to deliver 20 million doses by the end of March, an executive said earlier this week at a congressional hearing. “If -- if -- the FDA approves the use of this new vaccine," President Joe Biden said Thursday at an event to celebrate 50 million doses administered since he took office, “we have a plan to roll it out as quickly as Johnson & Johnson can make it." J&J’s scientists and FDA staff are scheduled to review the data behind the vaccine in separate presentations. The company has a contract to deliver 100 million doses to the U.S. by the end of June.

Source: Mint February 26, 2021 16:41 UTC